panel: current realities of make vs. buy for cell & gene therapy manufacturing
Published 2 years ago • 169 plays • Length 58:25Download video MP4
Download video MP3
Similar videos
-
52:32
panel: when does investing in cell and gene therapy make business sense?
-
41:38
panel: durable gmp compliance for cell and gene therapies
-
55:09
panel: myth vs reality - implementing payment arrangements for cell and gene therapies
-
44:30
panel: gene therapy manufacturing
-
24:29
meeting regulatory requirements for cell and gene therapy manufacturing
-
23:40
expediting the development of cell and gene therapy
-
59:45
webinar: manufacturing challenges facing cell and gene therapy
-
6:20
capability for cell and gene therapy manufacturing: arm studios interview with audrey greenberg
-
1:00:31
cell and gene therapies manufacturing: exploring next-generation platform technologies
-
1:09:06
the future of cdmo networks in cell and gene therapy
-
1:21:38
overcoming challenges to gene therapy manufacturing workshop
-
59:51
panel: next generation cell and gene therapy in oncology
-
16:25
fda’s efforts to advance the development and approval of cellular and gene therapies
-
1:00:23
panel: alternative ipo strategies for cell and gene therapy companies
-
1:02:29
panel: safety and efficacy considerations for cell and gene therapies
-
1:02:39
a-cell: manufacturing of cell-based therapies
-
1:11:29
panel: acceptance and uptake of cell and gene therapies: lessons learned and future focus
-
50:13
panel: cell therapy manufacturing
-
59:51
panel: what cell & gene therapy investors are looking for now